ReviewESMO open2024
Open questions, current challenges, and future perspectives in targeting human epidermal growth factor receptor 2-low breast cancer.
G Curigliano et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
18 papers cite it
this papercites it